UNA S RYAN Insider Trading
Get free email notifications about insider trading for UNA S RYAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of UNA S RYAN. UNA S RYAN is a President & CEO in Celldex Therapeutics, Inc. ($AVAN) and a Director in ALBANY MOLECULAR RESEARCH INC ($AMRI) and a Director in Cortexyme, Inc. ($CRTX).
Address: 329 HAMMOND STREET CHESTNUT HILL 02467 MA
Companies in which UNA S RYAN is an Insider
ALBANY MOLECULAR RESEARCH INC
Trading Symbol: AMRIIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of UNA S RYAN: Director
Holdings: 46,845 shares
Current Value: $863,822
Latest Transaction: Feb 10 2017
$AMRI Market Capitalization: $765.67M
$AMRI Previous Close: $18.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Celldex Therapeutics, Inc.
Trading Symbol: CLDXIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of UNA S RYAN: President & CEO
Holdings: 899,213 shares
Latest Transaction: Mar 11 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cortexyme, Inc.
Trading Symbol: CRTXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of UNA S RYAN: Director
Holdings: 2,875 shares
Latest Transaction: Jun 09 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of UNA S RYAN
Sentiment: All, AMRI, CLDX, CRTX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2020 | CRTX | Cortexyme, Inc. | RYAN UNA S | Director | Option Exercise | A | 41.73 | 11,029 | 460,240 | 11,029 | |
Mar 12 2020 | CRTX | Cortexyme, Inc. | RYAN UNA S | Director | Buy | P | 17.00 | 2,875 | 48,875 | 2,875 | 0 to 2.9 K |
Mar 12 2020 | CRTX | Cortexyme, Inc. | RYAN UNA S | Director | Buy | P | 17.00 | 2,875 | 48,875 | 2,875 | 0 to 2.9 K |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 18.41 | 9,358 | 172,281 | 9,358 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 0.00 | 3,802 | 0 | 46,845 | 43 K to 46.8 K (+8.83 %) |
Oct 06 2016 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | M | 11.83 | 5,000 | 59,150 | 0 | |
Oct 06 2016 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Payment of Exercise | F | 16.91 | 3,498 | 59,151 | 43,043 | 46.5 K to 43 K (-7.52 %) |